Work

Correction to: ExoDx prostate test as a predictor of outcomes of high-grade prostate cancer – an interim analysis

Year: 2023

Type: erratum

Abstract: Correction to: Prostate Cancer and Prostatic Diseases https://doi.org/10.1038/s41391-023-00675-1 , published online 16 May 2023

Source: Prostate Cancer and Prostatic Diseases

DOI: 10.1038/s41391-023-00681-3

Authors: Ronald Tutrone, Ben Lowentritt, Brian Neuman, Michael J. Donovan, Elliot Hallmark, T. Jeffrey Cole, Yiyuan Yao, Claire Biesecker, Sonia Kumar, Vinita Verma, Grannum R. Sant, Jason Alter, Johan Skog

Institutions: Chesapeake Urology Associates, Icahn School of Medicine at Mount Sinai, Exosome Diagnostics (United States), Tufts University

Language: English

Topic: Prostate Cancer Diagnosis and Treatment

Subfield: Urology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,690

OpenAlex ID: W4381165821

Cites:

Cited by: 1

Related to: 10